SuperworthBlack Diamond Therapeutics shares outstanding BDTX
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 57.4M
- On a year earlier
- +1.0%
- more shares
Black Diamond Therapeutics had 57.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 57.1M | +1% |
| FY2024 | 56.6M | +10% |
| FY2023 | 51.6M | +42% |
| FY2022 | 36.4M | +0% |
| FY2021 | 36.2M | +1% |
| FY2020 | 36M | +1583% |
| FY2019 | 2.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 57.4M | +1% | |
| Q1 FY26 | 57.2M | −1% | |
| Q4 FY25 | 57.1M | +1% | |
| Q3 FY25 | 56.9M | +1% | |
| Q2 FY25 | 56.8M | +3% | |
| Q1 FY25 | 57.7M | +11% | |
| Q4 FY24 | 56.6M | +10% | |
| Q3 FY24 | 56.5M | +11% | |
| Q2 FY24 | 55.2M | +51% | |
| Q1 FY24 | 51.8M | +42% | |
| Q4 FY23 | 51.6M | +42% | |
| Q3 FY23 | 50.9M | +40% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Black Diamond Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.